Gezielt nachschlagen
Suche
Suche startet nach einer kurzen Eingabepause.
20 angezeigte Treffer · Seite 3, keine Gesamtzahl für „Entecavir“
Suchtreffer
Begriffe & Kennungen
Entecavir Accord · 4.8 · Cases of lactic acidosis have been reported, often in association with hepatic decompensation, other serious m
Eintrag öffnenEntecavir Accord · 4.8 · Exacerbations after discontinuation of treatment: acute exacerbations of hepatitis have been reported in patie
Eintrag öffnenEntecavir Accord · 4.8 · Exacerbations during treatment: in studies with nucleoside naive patients, on treatment ALT elevations > 10 ti
Eintrag öffnenEntecavir Accord · 4.8 · Experience in patients co-infected with HIV: the safety profile of entecavir in a limited number of HIV/HBV co
Eintrag öffnenEntecavir Accord · 4.8 · Experience in patients with decompensated liver disease: the safety profile of entecavir in patients with deco
Eintrag öffnenEntecavir Accord · 4.8 · Gender/age: there was no apparent difference in the safety profile of entecavir with respect to gender ( 25%
Eintrag öffnenEntecavir Accord · 4.8 · Immune system disorders: rare : anaphylactoid reaction Psychiatric disorders: common : insomnia Nervous system
Eintrag öffnenEntecavir Accord · 4.8 · In the clinical trials entecavir treatment was discontinued if patients achieved a prespecified response. If t
Eintrag öffnenEntecavir Accord · 4.8 · Laboratory test abnormalities: In clinical trials with nucleoside-naive patients, 5% had ALT elevations > 3 ti
Eintrag öffnenEntecavir Accord · 4.8 · Laboratory test abnormalities: through week 48 among entecavir-treated patients with decompensated liver disea
Eintrag öffnenEntecavir Accord · 4.8 · Reporting of suspected adverse reactions Reporting suspected adverse reactions after authorisation of the medi
Eintrag öffnenEntecavir Accord · 4.8 · The safety of entecavir in paediatric patients from 2 to < 18 years of age is based on two clinical trials in
Eintrag öffnenEntecavir Accord · 4.8 · Treatment beyond 48 weeks: continued treatment with entecavir for a median duration of 96 weeks did not reveal
Eintrag öffnenEntecavir Accord · 4.8 · a. Summary of the safety profile In clinical trials in patients with compensated liver disease, the most commo
Eintrag öffnenEntecavir Accord · 4.8 · b. Tabulated list of adverse reactions Assessment of adverse reactions is based on experience from postmarketi
Eintrag öffnenEntecavir Accord · 4.8 · c. Description of selected adverse reactions
Eintrag öffnenEntecavir Accord · 4.8 · d. Paediatric population
Eintrag öffnenEntecavir Accord · 4.8 · e. Other special populations
Eintrag öffnenEntecavir Viatris (previously Entecavir Mylan)
Eintrag öffnenEntecavir Viatris (previously Entecavir Mylan) · 4.1 Therapeutic indications · 1
Eintrag öffnen